TCL Archive In Brief: Cancer Patient Said To Face Job Discrimination; A Goal Of New Epidemiology College: Certification April 30, 1982
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006